Your Window into Emerging FDA and CMS Regulatory Policies Affecting Life Sciences
CBI’s FDA/CMS Summit draws the highest leadership at the FDA and CMS and delivers best available information on FDA and CMS priorities, policy changes, evidence-based practice, federal review processes on various areas of biopharma like CDER, CBER, CDRH and the most cutting-edge advances in healthcare and technology. This event is geared to the information needs of C-Suite biopharmaceutical executives, Directors/VPs of Regulatory/Government Affairs, FDA regulators, consultants, law firms, PhRMA and big pharmaceutical companies.
Explore Patient-Centric Approaches to Trial Design, Recruitment and Access to Enhanced Outcomes
The 2019 Conference of the Tissue Engineering and Regenerative Medicine International Society – Americas Chapter (TERMIS-AM) will be held in Orlando in December. The theme of the conference is “Transversal, Translational and Transformative.” Transversal knowledge. Translational approaches. Transformative solutions. We will strive to create an agenda that fosters integrative and circular routes of thinking, inspiring young minds, transforming old visions, and accelerating clinical solutions.
The 10th is taking place 12th–14th November, 2019 in Barcelona, Spain; and is not an event to be missed.
Now recognised as the largest and most established European orphan drug event, we are once again proud to deliver another outstanding speaker line-up and a content-filled agenda that represents the whole orphan drug landscape. The 10th annual event will address the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases.
For 2019 we will be expanding the meeting further with a dedicated co-conference on Cell & Gene Therapy and even more dedicated content and tracks than ever before on Clinical/Product Development, Market Access & Pricing, Manufacture, Science & Strategy, Pitch & Partner and Precision Medicine.
We will also continue the highly popular Pre-Congress Workshops. So make sure you’re there this November in Barcelona.
Download Full agenda here
Book your ticket here
The 25th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
BIO-Europe’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Learn more here https://ebdgroup.knect365.com/bioeurope/.
Join the ISSCR for From Stem Cell Biology to New Therapies, 6-8 November 2019 in Toronto, Canada. This international symposium is co-sponsored by BlueRock Therapeutics. Learn more and register at www.isscr.org/toronto2019
Join us for a unique 2-day symposium where leading scientists will come together to explore the power of the immune system and its role in the development of tomorrow’s therapies. Featuring thought-provoking presentations, panel discussions and a networking reception, each day’s dedicated agenda will cover the latest research, new modalities, and regulatory approaches that expedite development. Register for the full conference or your specific area of interest. Download the full agenda and register here for the full conference or your specific area of interest.
Day 1: Cellular and Gene Therapies
The presentations throughout the day will focus on the complexities of cell and gene therapy development and will cover a range of topics including strategies to navigate through the current regulatory framework, challenges in developing therapeutics for diseases requiring targeted administration to specific organ systems, and genomic editing technologies for these product types.
Day 2: Immuno-Oncology
Will provide a forum where scientists will have the opportunity to review the current state of research for immuno-oncology and identify ways to develop therapies across various modalities, including; antibodies therapies, CAR-T cells, viral vaccines, oncolytic viruses and bicyclic peptides. We will consider novel strategies on the horizon, and explore how the next generation of modalities may augment checkpoint inhibitors or act as stand-alone therapies, and how they will change the landscape of oncology drug discovery.
The International Conference on Biofabrication (Biofabrication 2019) is the annual meeting of the International Society for Biofabrication.
